2024 Q2 Form 10-Q Financial Statement

#000150707924000017 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.133B $1.097B
YoY Change -0.24% -2.21%
Cost Of Revenue $642.1M $627.3M
YoY Change -2.16% -3.93%
Gross Profit $491.0M $470.0M
YoY Change 2.38% 0.19%
Gross Profit Margin 43.33% 42.84%
Selling, General & Admin $409.1M $401.1M
YoY Change 6.6% 9.72%
% of Gross Profit 83.31% 85.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $58.38M $56.42M
YoY Change 17.53% 21.73%
% of Gross Profit 11.89% 12.0%
Operating Expenses $419.7M $410.7M
YoY Change 9.37% 9.93%
Operating Profit $71.33M $59.31M
YoY Change -25.6% -37.9%
Interest Expense $663.0K $1.955M
YoY Change -122.88% -59.79%
% of Operating Profit 0.93% 3.3%
Other Income/Expense, Net
YoY Change
Pretax Income $70.67M $57.36M
YoY Change -23.25% -36.73%
Income Tax $14.00M $7.324M
% Of Pretax Income 19.81% 12.77%
Net Earnings $56.67M $50.03M
YoY Change -20.69% -30.05%
Net Earnings / Revenue 5.0% 4.56%
Basic Earnings Per Share $0.53 $0.47
Diluted Earnings Per Share $0.52 $0.46
COMMON SHARES
Basic Shares Outstanding 107.0M shares 106.8M shares
Diluted Shares Outstanding 108.3M shares 108.3M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $138.1M $57.43M
YoY Change 3210.07% 1040.76%
Cash & Equivalents $138.1M $57.43M
Short-Term Investments
Other Short-Term Assets $53.42M $49.75M
YoY Change -5.61% -8.39%
Inventory $1.037B $1.032B
Prepaid Expenses
Receivables $109.3M $101.0M
Other Receivables $4.109M $15.83M
Total Short-Term Assets $1.342B $1.256B
YoY Change 0.5% -5.45%
LONG-TERM ASSETS
Property, Plant & Equipment $1.701B $1.651B
YoY Change -37.04% 22.78%
Goodwill $257.9M $257.9M
YoY Change -0.36% 0.97%
Intangibles $152.0M $153.0M
YoY Change -2.37% 0.9%
Long-Term Investments
YoY Change
Other Assets $7.510M $7.211M
YoY Change -68.91% -20.65%
Total Long-Term Assets $3.476B $3.403B
YoY Change 10.7% 13.17%
TOTAL ASSETS
Total Short-Term Assets $1.342B $1.256B
Total Long-Term Assets $3.476B $3.403B
Total Assets $4.818B $4.659B
YoY Change 7.65% 7.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $698.7M $641.2M
YoY Change 5.12% 12.0%
Accrued Expenses $302.3M $287.0M
YoY Change -30.51% 0.51%
Deferred Revenue $13.30M $14.20M
YoY Change -7.64% -1.39%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.103M $2.103M
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $1.149B $1.074B
YoY Change 2.96% 6.67%
LONG-TERM LIABILITIES
Long-Term Debt $194.7M $194.8M
YoY Change -15.39% -35.43%
Other Long-Term Liabilities $11.44M $11.15M
YoY Change -99.11% 10.22%
Total Long-Term Liabilities $1.622B $1.604B
YoY Change 6.91% 0.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.149B $1.074B
Total Long-Term Liabilities $1.622B $1.604B
Total Liabilities $2.771B $2.678B
YoY Change 3.97% 2.73%
SHAREHOLDERS EQUITY
Retained Earnings $1.523B $1.466B
YoY Change 15.97% 18.08%
Common Stock $523.3M $513.8M
YoY Change 6.16% 6.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.047B $1.981B
YoY Change
Total Liabilities & Shareholders Equity $4.818B $4.659B
YoY Change 7.65% 7.46%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $56.67M $50.03M
YoY Change -20.69% -30.05%
Depreciation, Depletion And Amortization $58.38M $56.42M
YoY Change 17.53% 21.73%
Cash From Operating Activities $194.0M $147.5M
YoY Change -14.31% -41.06%
INVESTING ACTIVITIES
Capital Expenditures $113.9M $111.7M
YoY Change -18.49% -19.88%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$113.9M -$111.7M
YoY Change -27.4% -19.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 593.0K -$12.78M
YoY Change -100.84% -88.95%
NET CHANGE
Cash From Operating Activities 194.0M $147.5M
Cash From Investing Activities -113.9M -$111.7M
Cash From Financing Activities 593.0K -$12.78M
Net Change In Cash 80.64M $23.04M
YoY Change -9443.8% -584.12%
FREE CASH FLOW
Cash From Operating Activities $194.0M $147.5M
Capital Expenditures $113.9M $111.7M
Free Cash Flow $80.04M $35.82M
YoY Change -7.56% -67.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration
SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
627263000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
652934000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
470026000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
469118000 usd
CY2024Q1 us-gaap Selling Expense
SellingExpense
334345000 usd
CY2023Q1 us-gaap Selling Expense
SellingExpense
303671000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
66777000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61911000 usd
CY2024Q1 us-gaap Pre Opening Costs
PreOpeningCosts
9593000 usd
CY2023Q1 us-gaap Pre Opening Costs
PreOpeningCosts
8020000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
410715000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
373602000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
59311000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
95516000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1955000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
4862000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
57356000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
90654000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7324000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19130000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
50032000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
71524000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-970000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-849000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
49062000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
70675000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1930990000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7232000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3854000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2720000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13057000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
50032000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1980801000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1657176000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6741000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2130000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2558000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10863000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-849000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
71524000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1728417000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
50032000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
71524000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
56423000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46352000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7530000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7211000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7232000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6741000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
576000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1434000 usd
CY2024Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-37000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
177000 usd
CY2024Q1 us-gaap Amortization Of Deferred Hedge Gains
AmortizationOfDeferredHedgeGains
28000 usd
CY2023Q1 us-gaap Amortization Of Deferred Hedge Gains
AmortizationOfDeferredHedgeGains
28000 usd
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1438000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-6740000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-74020000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-111189000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-35079000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
47176000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7905000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-68733000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
13186000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
25495000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2918000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4358000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4990000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5364000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
147510000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
250280000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
111688000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
139398000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-111688000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-139398000 usd
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
526000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
526000 usd
CY2024Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
258600000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
215400000 usd
CY2024Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
258600000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
319100000 usd
CY2024Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5769000 usd
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5241000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3854000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2130000 usd
CY2024Q1 fnd Proceeds From Issuance Of Common Stock Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockEmployeeStockPurchasePlan
2720000 usd
CY2023Q1 fnd Proceeds From Issuance Of Common Stock Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockEmployeeStockPurchasePlan
2558000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13057000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10863000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12778000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-115642000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23044000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4760000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34382000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9794000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57426000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5034000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
68360000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
55701000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
1195000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
4692000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1665000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1651000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
100091000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
109161000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
36 state
CY2024Q1 fnd Number Of Distribution Centers
NumberOfDistributionCenters
4 distributioncenter
CY2024Q1 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year is the 52- or 53-week period ending on the Thursday on or preceding December 31st. The fiscal year ending December 26, 2024 (“fiscal 2024”) and the fiscal year ended December 28, 2023 (“fiscal 2023”) include 52 weeks. 52-week fiscal years consist of thirteen-week periods in each quarter of the fiscal year. When a 53-week fiscal year occurs, the Company reports the additional week at the end of the fiscal fourth quarter.</span></div>
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
72600000 usd
CY2024Q1 fnd Contract With Customer Liability Current Loyalty Program
ContractWithCustomerLiabilityCurrentLoyaltyProgram
47500000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14200000 usd
CY2024Q1 fnd Contract With Customer Liability Current Unredeemed Gift Cards
ContractWithCustomerLiabilityCurrentUnredeemedGiftCards
10900000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
69600000 usd
CY2023Q4 fnd Contract With Customer Liability Current Loyalty Program
ContractWithCustomerLiabilityCurrentLoyaltyProgram
45600000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
11300000 usd
CY2023Q4 fnd Contract With Customer Liability Current Unredeemed Gift Cards
ContractWithCustomerLiabilityCurrentUnredeemedGiftCards
12700000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12900000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1097289000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1122052000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
201870000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
202396000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
2103000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
2103000 usd
CY2024Q1 fnd Long Term Debt Gross Excluding Current Maturities
LongTermDebtGrossExcludingCurrentMaturities
199767000 usd
CY2023Q4 fnd Long Term Debt Gross Excluding Current Maturities
LongTermDebtGrossExcludingCurrentMaturities
200293000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
4931000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
5354000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
194836000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
194939000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1577000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2103000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2629000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
195561000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
201870000 usd
CY2024Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
3802000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
6186000 usd
CY2024Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
1847000 usd
CY2023Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
1324000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1955000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
4862000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.128
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.211
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.058
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
53279000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
48540000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
20127000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
16039000 usd
CY2024Q1 us-gaap Sublease Income
SubleaseIncome
682000 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
679000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
72724000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
63900000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
28.43
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
152243000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
210965000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
198137000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
187562000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
167828000 usd
CY2024Q1 fnd Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
1214340000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2131075000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
664169000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1466906000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
129150000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1337756000 usd
CY2024Q1 fnd Lessee Operating Lease Lease Not Yet Commenced Amount
LesseeOperatingLeaseLeaseNotYetCommencedAmount
487900000 usd
CY2024Q1 fnd Lessee Operating Lease Option To Extend Amount
LesseeOperatingLeaseOptionToExtendAmount
255000000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
50300000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
46400000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7232000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6741000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1607341 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
28.51
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
170713 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
22.58
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1132 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
92.56
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1435496 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.16
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1419169 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
50032000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
71524000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106770000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105962000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1485000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1756000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108255000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107718000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2024Q1 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
116000000 usd
CY2023Q4 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
114000000 usd
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001507079-24-000017-index-headers.html Edgar Link pending
0001507079-24-000017-index.html Edgar Link pending
0001507079-24-000017.txt Edgar Link pending
0001507079-24-000017-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fnd-20240328.htm Edgar Link pending
fnd-20240328.xsd Edgar Link pending
fnd-20240328xex311.htm Edgar Link pending
fnd-20240328xex312.htm Edgar Link pending
fnd-20240328xex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
fnd-20240328_cal.xml Edgar Link unprocessable
fnd-20240328_def.xml Edgar Link unprocessable
fnd-20240328_lab.xml Edgar Link unprocessable
fnd-20240328_pre.xml Edgar Link unprocessable
fnd-20240328_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable